Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biondvax Pharma ADR (NQ: BVXV ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Sep 6, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biondvax Pharma ADR < Previous 1 2 3 4 5 6 7 8 Next > New Research Shows Brain Stimulation Improves Reading Ability of Macular Degeneration Patients December 28, 2022 Via Investor Brand Network BioMedNewsBreaks – Aegis Capital Corp. Acted as Sole Bookrunner on BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) $8M Underwritten Public Offering December 22, 2022 Via Investor Brand Network Aegis Capital Corp. Acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) December 21, 2022 Via ACCESSWIRE Experts Push for More Studies into Link Between Asthma, Female Sex Hormones December 21, 2022 Via Investor Brand Network BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Closes $8M Underwritten Public Offering December 20, 2022 Via Investor Brand Network BiondVax Announces Closing of $8 Million Underwritten Public Offering December 20, 2022 From BiondVax Pharmaceuticals Ltd. Via GlobeNewswire Why Biondvax Pharmaceuticals Stock Is Getting Obliterated During Friday's Trading Session December 16, 2022 Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) shares are trading lower by 58.60% to $3.64 during Friday's session after the company priced its 1.6 million unit offering at $5 per unit. Via Benzinga Dow Tumbles 400 Points; Maxar Technologies Shares Spike Higher December 16, 2022 U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 400 points on Friday. Via Benzinga Nasdaq Falls Over 100 Points; Crude Oil Drops Sharply December 16, 2022 U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday. Via Benzinga Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session December 16, 2022 Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 16, 2022 Via Benzinga BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Pricing on Public Offering, Expects to Raid $8M December 16, 2022 Via Investor Brand Network Dow Drops 200 Points; Accenture Posts Upbeat Results December 16, 2022 U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday. Via Benzinga BiondVax Announces Pricing of $8 Million Underwritten Public Offering December 16, 2022 From BiondVax Pharmaceuticals Ltd. Via GlobeNewswire BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in ‘Stock2Me’ Podcast December 13, 2022 Via Investor Brand Network Exposures COVID-19 Psoriasis Patients Report Being Embarrassed Because of Flare-Ups in Intertriginous Areas December 13, 2022 Via Investor Brand Network BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Innovative Inhaled COVID-19 NanoAb Therapy Shows Statistically Significant Efficacy Results in Preclinical Study December 13, 2022 Via Investor Brand Network Exposures COVID-19 BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Regains Compliance with Nasdaq Listing Rules December 12, 2022 Via Investor Brand Network BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Investment Research Report December 09, 2022 Via Investor Brand Network Exposures COVID-19 Teens Suffering from Concussions Could Benefit from Screen Time December 06, 2022 Via Investor Brand Network BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Names Experienced Researcher as Advisory Board Member December 06, 2022 Via Investor Brand Network Exposures COVID-19 Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board December 06, 2022 From BiondVax Pharmaceuticals Ltd. Via GlobeNewswire BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q3 2022 Financial Results, Corporate Updates November 30, 2022 Via Investor Brand Network BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update November 30, 2022 From BiondVax Pharmaceuticals Ltd. Via GlobeNewswire BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Confirms Inhalation Concept of NanoAb as Therapy for COVID-19 November 29, 2022 Via Investor Brand Network Exposures COVID-19 BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Pipeline Focused on Creating Innovative Immunotherapeutic Products for Treating Underserved Infectious and Autoimmune Diseases November 29, 2022 Via Investor Brand Network Exposures COVID-19 BiondVax reports successful results in preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy November 29, 2022 From BiondVax Pharmaceuticals Ltd. Via GlobeNewswire Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday November 28, 2022 Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share. Via Benzinga Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day Session November 25, 2022 Gainers Peak Bio, Inc. (NYSE: PKBO) shares jumped 49.1% to $7.08. Via Benzinga BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Director of Communications and Investor Relations Presents at LD Micro Main Event November 22, 2022 Via Investor Brand Network < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.